Literature DB >> 20529143

The use of Matriderm and autologous skin grafting in the treatment of diabetic ulcers: a case report.

Valerio Cervelli1, Lucilla Lucarini, Caterina Cerretani, Diana Spallone, Ludovico Palla, Lorenzo Brinci, Barbara De Angelis.   

Abstract

The aim of our case report was to analyse the results obtained with the Matriderm system and autologous skin grafting for the surgical treatment of diabetic ulcers. We recruited one patient with diabetic ulcers admitted at the Department of Plastic and Reconstructive Surgery, University of Rome 'Tor Vergata'. The patient underwent Matriderm system and autologous skin grafting for diabetic ulcer treatment. After just a single treatment, we obtained reduction in ulcer after 15 days from the surgical treatment. We achieved a reduction in pain and exudate secretion of the ulcer. We noticed an almost complete restoration of the missing volume and good quality of skin. Matriderm system and autologous skin grafting is a simple, safe and feasible technique. This method, when compared with other methods of treatment, is simple, cheap, less time consuming and does not require sophisticated laboratory facilities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20529143      PMCID: PMC7951783          DOI: 10.1111/j.1742-481X.2010.00687.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  24 in total

Review 1.  Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach.

Authors:  S D Hobbs; A W Bradbury
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-10       Impact factor: 7.069

Review 2.  Management of peripheral arterial disease in primary care.

Authors:  Paul Burns; Stephen Gough; Andrew W Bradbury
Journal:  BMJ       Date:  2003-03-15

3.  Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.

Authors:  T J Wieman; J M Smiell; Y Su
Journal:  Diabetes Care       Date:  1998-05       Impact factor: 19.112

4.  Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study.

Authors:  Caroline A Abbott; Adam P Garrow; Anne L Carrington; Julie Morris; Ernest R Van Ross; Andrew J Boulton
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

Review 5.  Principles and practice of antibiotic therapy of diabetic foot infections.

Authors:  B A Lipsky; A R Berendt
Journal:  Diabetes Metab Res Rev       Date:  2000 Sep-Oct       Impact factor: 4.876

6.  Reliability of free-flap coverage in diabetic foot ulcers.

Authors:  Omer Ozkan; O Koray Coşkunfirat; H Ege Ozgentaş
Journal:  Microsurgery       Date:  2005       Impact factor: 2.425

Review 7.  Management of leg ulcers.

Authors:  P K Sarkar; S Ballantyne
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

Review 8.  Antibiotic selection for diabetic foot infections: a review.

Authors:  B A Cunha
Journal:  J Foot Ankle Surg       Date:  2000 Jul-Aug       Impact factor: 1.286

Review 9.  Preventing foot ulcers in patients with diabetes.

Authors:  Nalini Singh; David G Armstrong; Benjamin A Lipsky
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

Review 10.  Wound healing and treatments for people with diabetic foot ulcers.

Authors:  William J Jeffcoate; Patricia Price; Keith G Harding
Journal:  Diabetes Metab Res Rev       Date:  2004 May-Jun       Impact factor: 4.876

View more
  9 in total

1.  Skin necrosis of scrotum due to endovascular embolisation: a case report.

Authors:  Valerio Cervelli; Lorenzo Brinci; Ludovico Palla; Diana Spallone; Valentina Izzo; Cristiano Beniamino Curcio; Lucilla Lucarini; Barbara De Angelis
Journal:  Int Wound J       Date:  2011-08-31       Impact factor: 3.315

2.  The use of MatriDerm® and skin grafting in post-traumatic wounds.

Authors:  Valerio Cervelli; Lorenzo Brinci; Diana Spallone; Eleonora Tati; Ludovico Palla; Lucilla Lucarini; Barbara De Angelis
Journal:  Int Wound J       Date:  2011-05-12       Impact factor: 3.315

3.  Matriderm® 1 mm versus Integra® Single Layer 1.3 mm for one-step closure of full thickness skin defects: a comparative experimental study in rats.

Authors:  Sophie Böttcher-Haberzeth; Thomas Biedermann; Clemens Schiestl; Fabienne Hartmann-Fritsch; Jörg Schneider; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2012-02       Impact factor: 1.827

4.  The surgical treatment of rhinophyma-Complete excision and single-step reconstruction by use of a collagen-elastin matrix and an autologous non-meshed split-thickness skin graft.

Authors:  Harald-Franz Selig; David Benjamin Lumenta; Lars-Peter Kamolz
Journal:  Int J Surg Case Rep       Date:  2012-11-10

5.  A new model for preclinical testing of dermal substitutes for human skin reconstruction.

Authors:  Fabienne Hartmann-Fritsch; Thomas Biedermann; Erik Braziulis; Martin Meuli; Ernst Reichmann
Journal:  Pediatr Surg Int       Date:  2013-02-01       Impact factor: 1.827

6.  The use of split-thickness skin grafts on diabetic foot ulcerations: a literature review.

Authors:  Brant McCartan; Thanh Dinh
Journal:  Plast Surg Int       Date:  2012-05-14

Review 7.  Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing.

Authors:  Mahshid Kharaziha; Avijit Baidya; Nasim Annabi
Journal:  Adv Mater       Date:  2021-07-12       Impact factor: 32.086

8.  Chronic ulcers: MATRIDERM(®) system in smoker, cardiopathic, and diabetic patients.

Authors:  Barbara De Angelis; Pietro Gentile; Annarita Agovino; Alessia Migner; Fabrizio Orlandi; Pamela Delogu; Valerio Cervelli
Journal:  J Tissue Eng       Date:  2013-08-26       Impact factor: 7.813

Review 9.  Challenges in the Treatment of Chronic Wounds.

Authors:  Robert G Frykberg; Jaminelli Banks
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-09-01       Impact factor: 4.730

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.